PENUMBRA INC

PENUMBRA INC

Aktie · US70975L1070 · PEN · A14Y65 (XNYS)
Übersicht
AI-gestützte Analyse
Fundamental-Analyse
Was die Zahlen wirklich bedeuten – bevor der Markt es weiß.
Jetzt analysieren
News Sentiment
Kaufchance oder Alarmsignal? Was die aktuellen Nachrichten wirklich bedeuten.
Jetzt analysieren
Kaufen / Halten / Verkaufen
Kaufen, Halten oder Verkaufen? Das AI-Urteil auf einen Blick.
Jetzt analysieren
Risiko-Bewertung
Risiken erkennen, bevor sie zum Problem werden.
Jetzt analysieren
Fair Value
Zu teuer, fair bewertet oder ein Schnäppchen?
Jetzt analysieren
Neuste KI Analysen zu PENUMBRA INC
Analyst Grade Summary
gauge-img
Halten
Starker Kauf
Kaufen
Halten
Verkaufen
Starker Verkauf
0
9
13
0
0
Kein Kurs
28.04.2026 20:00
Aktuelle Kurse von PENUMBRA INC
BörseTickerWährungLetzter UmsatzKursTagesveränderung
XNYS: NYSE
NYSE
PEN
USD
28.04.2026 20:00
325,99 USD
-1,99 USD
-0,61 %
IEXG: IEX
IEX
PEN
USD
28.04.2026 19:59
326,30 USD
-1,68 USD
-0,51 %
XDQU: Quotrix
Quotrix
PIRSN70.DUSD
EUR
28.04.2026 05:27
280,40 EUR
-
XDUS: Düsseldorf
Düsseldorf
PIRSN70.DUSB
EUR
27.04.2026 14:00
279,00 EUR
-
XHAM: Hamburg
Hamburg
PIRSN70.HAMB
EUR
23.04.2026 06:12
282,20 EUR
-
ESG-Risiko-Rating
B Gering
Free Float & Liquidität
Free Float 96,96 %
Shares Float 38,05 M
Ausstehende Aktien 39,24 M
Investierte Fonds

Folgende Fonds haben in PENUMBRA INC investiert:

Fonds
iShares US Medical Devices UCITS ETF USD (Acc)
Vol. in Mio
293,54
Anteil (%)
0,53 %
Firmenprofil zu PENUMBRA INC Aktie
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, BMX96, DDC, and PX SLIM brands. It also provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand; aspiration-based thrombectomy systems for vascular applications under the Indigo System brand; and detachable embolic coil systems for peripheral embolization under the Ruby Coil and Ruby LP brand names. In addition, the company offers microcatheter for the delivery of detachable coils and occlusion devices under the LANTERN brand; and detachable, microcatheter-deliverable occlusion devices designed primarily to occlude peripheral vessels under the POD (Penumbra Occlusion Device) brand, as well as immersive computer-based technologies and immersive therapeutics to promote health, motor function, and cognition under the Real Immersive System brand; and a complementary device for use with Ruby Coil and POD for vessel occlusion under the Packing Coil and Packing Coil LP brands. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

Unternehmensdaten

Name PENUMBRA INC
Firma Penumbra, Inc.
Symbol PEN
Website https://www.penumbrainc.com
Heimatbörse XNYS NYSE
WKN A14Y65
ISIN US70975L1070
Wertpapierart Aktie
Sektor Healthcare
Branche Medical - Devices
CEO Adam Elsesser
Marktkapitalisierung 13 Mrd.
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 4,5 T
Adresse One Penumbra Place, 94502 Alameda
IPO Datum 2015-09-18

Aktien-Splits

Datum Split
16.11.2014 1:10

Ticker Symbole

Name Symbol
Düsseldorf PIRSN70.DUSB
Frankfurt 0P8.F
Hamburg PIRSN70.HAMB
NYSE PEN
Quotrix PIRSN70.DUSD
Weitere Aktien
Investoren, die PENUMBRA INC halten, haben auch folgende Aktien im Depot:
DT.BANK MTH 23/33
DT.BANK MTH 23/33 Anleihe
TRAVELCENTERS OF AMERICA INC  - 8.00% SENIOR NOTES DUE 2030
TRAVELCENTERS OF AMERICA INC - 8.00% SENIOR NOTES DUE 2030 Aktie